A citation-based method for searching scientific literature


List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
57

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
57

The DNA damage response: making it safe to play with knives.
Alberto Ciccia, Stephen J Elledge. Mol Cell 2010
28

DNA damage and the balance between survival and death in cancer biology.
Wynand P Roos, Adam D Thomas, Bernd Kaina. Nat Rev Cancer 2016
520
28

How cells ensure correct repair of DNA double-strand breaks.
Joonyoung Her, Samuel F Bunting. J Biol Chem 2018
126
28

A BRCA1-interacting lncRNA regulates homologous recombination.
Vivek Sharma, Simran Khurana, Nard Kubben, Kotb Abdelmohsen, Philipp Oberdoerffer, Myriam Gorospe, Tom Misteli. EMBO Rep 2015
79
28

DNA damage, aging, and cancer.
Jan H J Hoeijmakers. N Engl J Med 2009
28

Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks.
Flavia Michelini, Sethuramasundaram Pitchiaya, Valerio Vitelli, Sheetal Sharma, Ubaldo Gioia, Fabio Pessina, Matteo Cabrini, Yejun Wang, Ilaria Capozzo, Fabio Iannelli,[...]. Nat Cell Biol 2017
145
28

The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers.
Andrea K Watters, Emily S Seltzer, Danny MacKenzie, Melody Young, Jonathan Muratori, Rama Hussein, Andrej M Sodoma, Julie To, Manrose Singh, Dong Zhang. Genes (Basel) 2020
6
33

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
Diana Zatreanu, Helen M R Robinson, Omar Alkhatib, Marie Boursier, Harry Finch, Lerin Geo, Diego Grande, Vera Grinkevich, Robert A Heald, Sophie Langdon,[...]. Nat Commun 2021
12
28

PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells.
Sylvie M Noordermeer, Haico van Attikum. Trends Cell Biol 2019
113
28

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
929
28

A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors.
Jia Zhou, Camille Gelot, Constantia Pantelidou, Adam Li, Hatice Yücel, Rachel E Davis, Anniina Farkkila, Bose Kochupurakkal, Aleem Syed, Geoffrey I Shapiro,[...]. Nat Cancer 2021
17
28

Structure of the Helicase Domain of DNA Polymerase Theta Reveals a Possible Role in the Microhomology-Mediated End-Joining Pathway.
Joseph A Newman, Christopher D O Cooper, Hazel Aitkenhead, Opher Gileadi. Structure 2015
41
28

Mechanism of eukaryotic homologous recombination.
Joseph San Filippo, Patrick Sung, Hannah Klein. Annu Rev Biochem 2008
28

The essential kinase ATR: ensuring faithful duplication of a challenging genome.
Joshua C Saldivar, David Cortez, Karlene A Cimprich. Nat Rev Mol Cell Biol 2017
302
28

Genomic instability--an evolving hallmark of cancer.
Simona Negrini, Vassilis G Gorgoulis, Thanos D Halazonetis. Nat Rev Mol Cell Biol 2010
28

Targeting ATR in cancer.
Emilio Lecona, Oscar Fernandez-Capetillo. Nat Rev Cancer 2018
114
28

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
Yinghua Zhu, Yujie Liu, Chao Zhang, Junjun Chu, Yanqing Wu, Yudong Li, Jieqiong Liu, Qian Li, Shunying Li, Qianfeng Shi,[...]. Nat Commun 2018
44
14

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
14

The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment.
L J Monteiro, P Khongkow, M Kongsema, J R Morris, C Man, D Weekes, C-Y Koo, A R Gomes, P H Pinto, V Varghese,[...]. Oncogene 2013
58
14


Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways.
Sergej Skvortsov, Paul Debbage, Peter Lukas, Ira Skvortsova. Semin Cancer Biol 2015
52
14

DNA damage repair pathways in cancer stem cells.
Marcello Maugeri-Saccà, Monica Bartucci, Ruggero De Maria. Mol Cancer Ther 2012
107
14

FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair.
Yun-Yong Park, Sung Yun Jung, Nicholas B Jennings, Cristian Rodriguez-Aguayo, Guang Peng, Se-Ran Lee, Sang Bae Kim, Kyounghyun Kim, Sun-Hee Leem, Shiaw-Yih Lin,[...]. Carcinogenesis 2012
77
14

An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.
H E Lee, J H Kim, Y J Kim, S Y Choi, S-W Kim, E Kang, I Y Chung, I A Kim, E J Kim, Y Choi,[...]. Br J Cancer 2011
120
14

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.
Jun Tian, Fatmah Al Raffa, Meiou Dai, Alaa Moamer, Baharak Khadang, Ibrahim Y Hachim, Khldoun Bakdounes, Suhad Ali, Bertrand Jean-Claude, Jean-Jacques Lebrun. Br J Cancer 2018
28
14

Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.
Zachary Steinhart, Zvezdan Pavlovic, Megha Chandrashekhar, Traver Hart, Xiaowei Wang, Xiaoyu Zhang, Mélanie Robitaille, Kevin R Brown, Sridevi Jaksani, René Overmeer,[...]. Nat Med 2017
150
14

The Fanconi anaemia/BRCA pathway.
Alan D D'Andrea, Markus Grompe. Nat Rev Cancer 2003
623
14

Survivin contributes to DNA repair by homologous recombination in breast cancer cells.
Eloïse Véquaud, Grégoire Desplanques, Pascal Jézéquel, Philippe Juin, Sophie Barillé-Nion. Breast Cancer Res Treat 2016
35
14

FZD7 has a critical role in cell proliferation in triple negative breast cancer.
L Yang, X Wu, Y Wang, K Zhang, J Wu, Y-C Yuan, X Deng, L Chen, C C H Kim, S Lau,[...]. Oncogene 2011
181
14

Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.
Sophia B Chernikova, Rochelle B Nguyen, Jessica T Truong, Stephano S Mello, Jason H Stafford, Michael P Hay, Andrew Olson, David E Solow-Cordero, Douglas J Wood, Solomon Henry,[...]. J Clin Invest 2018
11
14

Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Yanli Tan, Qixue Wang, Yingbin Xie, Xiaoxia Qiao, Shun Zhang, Yanan Wang, Yongbin Yang, Bo Zhang. Int J Oncol 2019
23
14

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
344
14

FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance.
Gabriela Nestal de Moraes, Deborah Delbue, Karina L Silva, Marcela Cristina Robaina, Pasarat Khongkow, Ana R Gomes, Stefania Zona, Susanne Crocamo, André Luiz Mencalha, Lídia M Magalhães,[...]. Cell Signal 2015
70
14

Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.
Debangshu Samanta, Daniele M Gilkes, Pallavi Chaturvedi, Lisha Xiang, Gregg L Semenza. Proc Natl Acad Sci U S A 2014
304
14

Wnt signaling in triple-negative breast cancer.
Sö-G Pohl, N Brook, M Agostino, F Arfuso, A P Kumar, A Dharmarajan. Oncogenesis 2017
138
14

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Suling Liu, Yang Cong, Dong Wang, Yu Sun, Lu Deng, Yajing Liu, Rachel Martin-Trevino, Li Shang, Sean P McDermott, Melissa D Landis,[...]. Stem Cell Reports 2013
563
14

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.
Aurélie S Cazet, Mun N Hui, Benjamin L Elsworth, Sunny Z Wu, Daniel Roden, Chia-Ling Chan, Joanna N Skhinas, Raphaël Collot, Jessica Yang, Kate Harvey,[...]. Nat Commun 2018
157
14

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
P Khongkow, U Karunarathna, M Khongkow, C Gong, A R Gomes, E Yagüe, L J Monteiro, M Kongsema, S Zona, E P S Man,[...]. Oncogene 2014
81
14

Breast cancer.
Nadia Harbeck, Michael Gnant. Lancet 2017
740
14

WNT5A: a motility-promoting factor in Hodgkin lymphoma.
F Linke, S Zaunig, M M Nietert, F von Bonin, S Lutz, C Dullin, P Janovská, T Beissbarth, F Alves, W Klapper,[...]. Oncogene 2017
22
14

Survivin: a unique target for tumor therapy.
Himani Garg, Prerna Suri, Jagdish C Gupta, G P Talwar, Shweta Dubey. Cancer Cell Int 2016
199
14

Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.
Gabriele Corda, Gianluca Sala, Rossano Lattanzio, Manuela Iezzi, Michele Sallese, Giorgia Fragassi, Alessia Lamolinara, Hasan Mirza, Daniela Barcaroli, Sibylle Ermler,[...]. J Pathol 2017
41
14

Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families.
Oksana Voloshanenko, Philipp Gmach, Jan Winter, Dominique Kranz, Michael Boutros. FASEB J 2017
55
14

Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance.
Gaofeng Xiong, Rachel L Stewart, Jie Chen, Tianyan Gao, Timothy L Scott, Luis M Samayoa, Kathleen O'Connor, Andrew N Lane, Ren Xu. Nat Commun 2018
72
14

CD133 in Breast Cancer Cells: More than a Stem Cell Marker.
Federica Brugnoli, Silvia Grassilli, Yasamin Al-Qassab, Silvano Capitani, Valeria Bertagnolo. J Oncol 2019
32
14

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang. Cancers (Basel) 2019
68
14

Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy.
Jiabei He, Hong-Jen Lee, Suchandrima Saha, Diane Ruan, Hua Guo, Chia-Hsin Chan. Cell Death Dis 2019
24
14

Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists.
Ping Yin, Wei Wang, Zhongbo Zhang, Yu Bai, Jian Gao, Chenghai Zhao. Cancer Sci 2018
53
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.